Now Is A Suitable Moment For A Long-Term Purchase Of BioNTech SE ADR (NASDAQ: BNTX)
Currently, there are 239.74M common shares owned by the public and among those 239.44M shares have been available to trade. The company’s stock has a 5-day price change of -8.89% and -4.93% over the past three months. BNTX shares are trading -1.77% year to date (YTD), with the 12-month market performance up to 14.68% higher. […]
